|Bid||0.6390 x 1100|
|Ask||0.6449 x 1200|
|Day's Range||0.6200 - 0.6549|
|52 Week Range||0.2400 - 1.9400|
|Beta (5Y Monthly)||3.49|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 05, 2020 - Nov 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.50|
NovaBay regains compliance with NYSE American listing standards
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces expanded Avenova® consumer marketing programs designed to generate greater awareness of its antimicrobial lid and lash spray and promote online sales. NovaBay has engaged PartnerCentric, Inc. for affiliate marketing programs and HVM Communications for enhanced public relations featuring consumer-oriented, lifestyle messaging.
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the availability of "subscribe & save" for repeat orders of Avenova® antimicrobial lid & lash solution on Avenova.com and Amazon.com.